Evidence map›Paper›PMID 32811463›Full record

Trial reportBMC infectious diseases2020

The potential of CBC-derived ratios (monocyte-to-lymphocyte, neutrophil-to-lymphocyte, and platelet-to-lymphocyte) to predict or diagnose incident TB infection in Tanzanian adolescents.

Christiaan A Rees, Dwan B Pineros, Maryam Amour, Patricia Munseri, Jamila Said, Albert Magohe, Mecky Matee, Kisali Pallangyo, C Fordham von Reyn

Registry-linked trialOpen access · goldAbstract readClinical Trial, Phase II
In one paragraph

Trial report in BMC infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02712424 (A Phase 2, Randomized, Placebo-Controlled, Double-Blind, Study of the Prevention of Infection With Mycobacterium Tuberculosis Among Adolescents Who Have Previously Received BCG), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02712424 phase2completednot on this map

A Phase 2, Randomized, Placebo-Controlled, Double-Blind, Study of the Prevention of Infection With Mycobacterium Tuberculosis Among Adolescents Who Have Previously Received BCG

TypeinterventionalSponsorDartmouth-Hitchcock Medical CenterRan2016 to 2020Enrolled625ConditionsTuberculosisArmsDAR-901, Sterile saline placebo
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Observational
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Christiaan A ReesGeisel School of Medicine at Dartmouth, One Rope Ferry Road, Hanover, NH, 03755, USA.
Dwan B PinerosGeisel School of Medicine at Dartmouth, One Rope Ferry Road, Hanover, NH, 03755, USA.
Maryam AmourMuhimbili University of Health and Allied Sciences, PO Box 65001, Dar es Salaam, Tanzania.
Patricia MunseriMuhimbili University of Health and Allied Sciences, PO Box 65001, Dar es Salaam, Tanzania.
Jamila SaidMuhimbili University of Health and Allied Sciences, PO Box 65001, Dar es Salaam, Tanzania.
Albert MagoheMuhimbili University of Health and Allied Sciences, PO Box 65001, Dar es Salaam, Tanzania.
Mecky MateeMuhimbili University of Health and Allied Sciences, PO Box 65001, Dar es Salaam, Tanzania.
Kisali PallangyoMuhimbili University of Health and Allied Sciences, PO Box 65001, Dar es Salaam, Tanzania.
C Fordham von ReynGeisel School of Medicine at Dartmouth, One Rope Ferry Road, Hanover, NH, 03755, USA. fvonreyn@gmail.com.
Muhimbili University of Health and Allied Sciences · TZDartmouth College · USDartmouth–Hitchcock Medical Center · US

Funding

Tuberculosis Research Institute at MUHASD43TW009573 · FIC · DARTMOUTH COLLEGE · PI ADAMS, LISA VIRGINIA · 2013 to 2022
$3.0M
FIC NIH HHS D43 TW009573
6 · The paper itself

Abstract

backgroundRatios of different immune cell populations (i.e., monocyte-to-lymphocyte, neutrophil-to-lymphocyte, and platelet-to-lymphocyte ratios) have been studied as a means of predicting future tuberculosis (TB) disease risk or to assist in the diagnosis of incident TB disease. No studies to-date, however, have evaluated the potential of these ratios to predict or assist in the diagnosis of incident TB infection - the first step in the natural history of TB disease.

methodsIn this prospective study, we evaluated the complete blood count (CBC)-derived metrics of monocyte-to-lymphocyte ratio (MLR), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) as predictors of future TB infection risk or aids in the diagnosis of TB infection among 145 Tanzanian adolescents enrolled in the DAR-901 vaccine trial, using paired CBCs and interferon-gamma release assays (IGRAs) obtained at 0, 60 and 720 days after study enrollment.

resultsAt baseline, there were no significant differences between study participants who remained persistently IGRA negative throughout the study period and those who subsequently converted to IGRA positive with respect to MLR (0.18 vs 0.17, p = 0.10), NLR (0.88 vs 1.02, p = 0.08), or PLR (115 vs 120, p = 0.28). Similarly, no significant differences were noted with respect to MLR, NLR, and PLR between IGRA converters and time-matched negative controls at the time of IGRA conversion. With respect to other blood cell measures, however, there were modest but significant differences between IGRA negatives and IGRA converters with respect to red blood cell count (4.8 vs 4.6 ×  10

conclusionsIn contrast to prior studies that have suggested that the ratios of different immune cell populations are associated with development of TB disease, our present findings do not demonstrate an association between these ratios and the development of TB infection. However, decreased red blood cell measures were associated with the subsequent development of TB infection, suggesting either that dysregulation of iron metabolism may play a role in TB pathogenesis or that following TB infection, iron dysregulation may precede IGRA positivity.

trial registrationClinicaltrials.gov NCT02712424 . Date of registration: March 14, 2016.

Indexed as

Blood PlateletsLymphocytesMonocytesNeutrophilsAdolescentBlood Cell CountFemaleHumansIncidenceInterferon-gamma Release TestsMaleProspective StudiesTanzaniaTuberculosisComplete blood countMycobacterium tuberculosisRed blood cellsTB vaccineTuberculosis infectionWhite blood cells

Identifiers

PMID32811463
PMCPMC7433160
OpenAlexW3062303919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.